Brodalumab 55513-0834
Product NDC
55513-0834- Manufacturer
- Amgen, Inc
- Dosage Form
- Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- February 15, 2017
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brodalumab | 140 mg/mL |
Packaging Options(1)
5062 mL in 1 CONTAINER (55513-834-81)